Statistics on Biotechnology Use Results by fields of operation Business Sector Biotechnology indicators by branch of activity. Unidades: specified in variables Total Companies Services Industry and Construction Agriculture No. of companies carrying out R&D in Biotechnology 1.348 818 427 103 %Companies according to biotechnology used: Genetic code 31 39,9 15,9 22,9 %Companies according to biotechnology used: Functional units 38,4 42,8 33,9 22,2 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 21,7 26,3 13,5 19,1 %Companies according to biotechnology used: Bioprocesses 50,3 40 74,4 33 %Companies according to biotechnology used: Sub-cellular organisms 8,2 11,1 4,3 2 %Companies according to biotechnology used: Bio-computing 24,1 34,1 9,2 6,9 %Companies according to biotechnology used: Nanobiotechnology 11,8 16,2 5,8 1 %Companies according to biotechnology used: Other 16,4 18,3 7,8 36,9 Companies in which biotechnology activities are: Main and/or exclusive 661 529 109 23 Companies in which biotechnology activities are: A secondary line of business 188 105 69 14 Companies in which biotechnology activities are: A tool necessary for production 500 184 250 66 %Company by field(s) of ultimate application of biotechnology use: Human Health 45,8 61,6 25,5 5 %Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 15,3 16,4 10,9 24,2 %Company by field(s) of ultimate application of biotechnology use: Food products 31,5 21 51,7 32,1 %Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production 23,7 20,2 21,3 60,7 %Company by field(s) of ultimate application of biotechnology use: Environment 15,5 16,1 15,1 13,1 %Company by field(s) of ultimate application of biotechnology use: Industry 13,4 14,2 14,2 4 Personnel in R&D in biotechnology (no. of persons) 15.744 9.783 4.929 1.032 Personnel in R&D in biotechnology (no. of persons): Research personnel 8.380 6.054 2.067 259 Personnel in R&D in biotechnology (no. of persons): Technical and auxiliary personnel 7.364 3.729 2.862 773 Personnel in R&D in biotechnology (no. of persons). Women 8.725 5.567 2.720 438 Personnel in R&D in biotechnology (no. of persons). Women: Research personnel 4.521 3.331 1.085 104 Personnel in R&D in biotechnology (no. of persons). Women: Technical and auxiliary personnel 4.204 2.236 1.635 334 Personnel in R&D in biotechnology (FTE) 11.523,2 7.360,5 3.555,3 607,5 Personnel in R&D in biotechnology (FTE): Research personnel 6.341,6 4.606,5 1.557,7 177,3 Personnel in R&D in biotechnology (FTE): Technical and auxiliary personnel 5.181,6 2.753,9 1.997,6 430,2 Personnel in R&D in biotechnology (FTE). Women 6.552,7 4.194,8 2.088,7 269,2 Personnel in R&D in biotechnology (FTE). Women: Research personnel 3.464,4 2.518,3 872,8 73,3 Personnel in R&D in biotechnology (FTE). Women: Technical and auxiliary personnel 3.088,3 1.676,5 1.215,9 195,9 Internal expenditure on R&D (thousands of euros) 1.037.887 632.044 365.151 40.692 1) By nature of the expense: Current expenses 939.471 572.886 329.570 37.015 1.1) Remuneration to research personnel 321.525 220.159 91.852 9.514 1.2) Remuneration to technical and auxiliary personnel 194.656 95.001 86.840 12.816 1.3) Other current expenses 423.290 257.726 150.878 14.686 2) By nature of the expense: Capital expenses 98.416 59.158 35.581 3.677 2.1) Land and buildings 10.150 6.669 2.905 577 2.2) Equipment and instruments 72.538 40.536 30.157 1.845 2.3) Acquisition of specific R&D software 5.713 3.849 1.726 138 2.4) Otros productos de propiedad intelectual específicos para I+D 10.015 8.104 794 1.117 1.1) By origin of the funds: Own funds 711.037 360.440 315.867 34.730 1.2) By origin of the funds: From companies 121.595 109.172 7.824 4.600 1.3) By origin of the funds: Public Administration funds 107.422 91.468 14.662 1.292 1.4) By origin of the funds: From Universities 192 182 11 0 1.5) By origin of the funds: From non profit private institutions 10.756 10.585 171 0 1.6) By origin of the funds: Foreign funds 86.884 60.196 26.617 70 Purchase of R&D services in biotechnology (thousands of euros) 145.440 75.379 68.977 1.085 Purchase of R&D services in biotechnology (thousands of euros): In Spain 95.870 52.783 42.361 726 Purchase of R&D services in biotechnology (thousands of euros): Abroad 49.570 22.595 26.616 359 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 39,8 48,3 26,8 25 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 12,5 12,2 13,6 10 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 18,5 19,9 16,4 16 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 11,2 11,4 10,8 11,9 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 15,6 18 11,7 12 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels 16,5 19,9 10,7 13,9 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 16,1 16,3 15,7 15,8 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 40 43,1 34,9 37 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 53,9 57,8 46,9 51,9 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 21,5 22,1 19 26,8 % Companies with income of an international origin related to biotechnological activities 22,2 24,1 22,3 7 % Turnover representing income of an international origin related to biotechnological activities 1,9 5,8 1,5 2,4 % Income of an international origin related to biotechnological activities distributed in: Income received from the EU 65,5 60,2 67,5 68,3 % Income of an international origin related to biotechnological activities distributed in: Income received from other countries 34,5 39,8 32,5 31,7 % Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services 86,3 84 87,3 85 % Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain 12,2 11,9 12,6 0 % Income of an international origin related with activities according to the classification: Operating source abroad 1,1 3,8 0,1 0 % Income of an international origin related with activities according to the classification: Other 0,4 0,3 0 15 Notas: '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent Fuente: National Statistics Institute